Rich, I have a few questions about your Simplified Methylation Protocol.
Freddd calls for the usage of various (what he calls "essential") supplements, such as Zinc, Calcium Magnesium, A, D, E, C Vitamins and Fish Oil as a foundation for his protocol.
Your protocol calls for similar supplements in the form of Yasko's
"Neurological Health Formula".
The difference is, that he recommends a much higher dosage of these "essential" supplements than you do. Unless I'm mistaken, your protocol calls for one tablet a day. Even on the label of Yasko's product, it recommends "six (6) tablets daily with meals".
In your opinion, is it OK to take more and would there be any benefit from doing so? Do you have a reason for recommending such a low dosage?
Actually, do you have upper limit recommendations for all of the supplements on your protocol? This is one aspect that I am very unclear about when reading about your recommendations. I get the impression that the dosages you mention are primarily meant as a starting point.
Also, I read elsewhere, that you recommend avoiding usage of Betaine HCI while on your protocol. I firmly believe that proper digestion is essential to recovery from CFS. Are other digestive aids suitable for use with this protocol, and if so, do you have any recommendations that might serve as an adequate substitute for Betaine HCI?
Hi, JPV.
Thank you for your interest in the Simplified Treatment Approach (STA). You have asked some very good questions, and I wish I had some very good answers to them! I'll first try to give you some short answers, as I can, and then give you some background so that you will understand why these answers aren't better than they are.
On the Yasko multi, it's true that on the bottle the specified daily dosage is 6 tablets per day. Dr. Yasko's own recommendation in her treatment program for autism and other neurological diseases, is only 2 tablets per day, which is the same as in the STA. The low dosages are specified because it has been found that some people with these disorders (particularly children with autism) are not able to tolerate higher dosages, especially at first, because they experience rather strong symptoms, presumably due to die-off of pathogens and/or mobilization of toxins. In my opinion, it is O.K. to take more, if a person can tolerate more. People seem to vary quite a bit in terms of what they can tolerate.
As far as upper limit dosages are concerned, I would suggest as a first cut observing the Tolerable Upper Limit dosages for the essential nutrients recommended by the Institute of Medicine of the National Academy of Sciences. Some of these are conservative, but I think that's a good place to start in determining upper limit dosages.
Some people do benefit from taking higher dosages of some of the supplements than are specified in the protocol I have suggested. If a person has the resources, I recommend doing some testing to see what their nutritional status is for the various essential nutrients, and then supplementing more of the ones that are found to be deficient. Before deciding (with one's physician) whether to try the STA, I favor running the Vitamin Diagostics Methylation Pathways Panel to find out if there is a partial methylation cycle, draining of folate metabolites from the cells, and glutathione depletion. This will indicate whether this treatment is likely to help, and it will also give baseline values for comparison later, to help in determining the progress of treatment, if the person enters upon the treatment. Symptoms aren't always reliable for determining the progress, because of die-off and detox symptoms. As a minimum set of tests to see what nutrients are needed, I favor the ones used by Dr. Yasko: The Genova Diagnostics metabolic analysis profile (which is a urine organic acids panel), the Doctor's Data urine amino acids panel, and the Doctor's Data urine toxic and essential elements panel. I think it's better to test to see what's needed than to just be shooting in the dark.
With regard to use of betaine-HCl, it's true that I recommended avoiding it while on the STA. The reason was that in the liver and kidneys, there is an alternate pathway that converts homocysteine into methionine, beside the methionine synthase pathway. The alternate pathway uses betaine. I made that recommendation based on Dr. Yasko's concern that overstimulation of the alternate pathway would shunt too much flow away from the main pathway, which is partially blocked and which needs to be stimuated because it is also associated with the folate metabolism, which in turn is needed for other purposes, including making DNA and RNA. I don't know of any objective clinical testing of this recommendation, and it's possible that my concern was unfounded. An alternative to betaine-HCl is the properly diluted HCl solution that is offered by Allergy Research Group. Note that it is very important that the correct concentration of HCl be used. Too high a concentration will damage the throat and esophagus. On the other hand, if it is too dilute, it won't serve its purpose well in the stomach.
O.K., now some background:
I'm a researcher, not a clinician. I developed a hypothesis to explain CFS, called the Glutathione Depletion--Methylation Cycle Block hypothesis, and presented it at the 2007 conference of the IACFS. It was based on work done by others in autism, which I applied to CFS because of the similarities I saw in the biochemistry in these two disorders. At the conference, Dr. David Bell, who has been involved with CFS since the outbreaks in the 80s, told me that he believed my hypothesis was valid, and he asked me for a treatment protocol to test it.
I had been exploring the existing biomedical treatments for autism, including those of the DAN! project and of Dr. Yasko, and had already been encouraging people with CFS to try these treatments. I had not seen much success with the DAN! treatments, at least the way I had been suggesting that they be applied, and the Yasko treatment was quite complex, expensive, and time-consuming, as it was genetically tailored to each patient. Knowing what I knew about the "managed care" under which physicians in the U.S. had to work, I was pretty sure that most physicians would not find the full Yasko treatment to be something they could implement in their practices.
I consulted with one of the people with CFS who was on the Yasko treatment program, and she suggested that I extract the part of the full Yasko treatment that deals specifically with lifting the methylation cycle block, the so-called "Step 2." I thought this was a good idea, and I selected 7 of the supplements in this step. I wrote to Dr. Bell, suggesting this "stripped-down" version of the full Yasko treatment program, and I also posted it to some CFS internet groups.
One person decided to try it, and she experienced some benefits right away, which she reported on the Pro-Health board in the spring of 2007. This led to an avalanche of others who decided to try it, and before long there were more than 60 people who had reported that they were trying it. After some experience, I removed two of the seven supplements, one because about half the people did not tolerate it well, and the other because of the cost. This made the protocol simpler, with only 5 supplements, and the cost was in the range of $2 to $3 per day. Most PWCs seemed to be able to deal with this degree of complexity and cost.
Also in 2007, Vitamin Diagnostics independently began to offer their Methylation Pathways Panel, primarily based on its potential use in autism. I found this panel to be very helpful in CFS as well, and began to encourage people with CFS to run it.
Shortly after this, the Ratna Ling Working Group on CFS was formed, and I was fortunate to be selected to participate in it. I was permitted to give a short talk to the group about my hypothesis and treatment and the early results. Neil Nathan, M.D., was also a member of the group. He believed what I had to say was worth trying, and went home and tried this protocol on some of his CFS and autism patients. The results were very favorable, and he then proposed a clinical study of this treatment. We were fortunate to be able to obtain financial support from an anonymous donor, and we carried out the clinical study in his practice in Springfield, MO. The results were again very favorable, and we presented them at the 2009 conference of the IACFS/ME.
Just after this study was completed, Metagenics, the supplier of two of the supplements in the protocol, changed the formulation of one of them (Intrinsi/B12/folate), eliminating folinic acid. I therefore replaced this supplement with another of their products, Actifolate, which still contains folinic acid, and this is in the revised protocol.
O.K., so this is the history of this treatment protocol. Is it optimum? Probably not, and probably the optimum treatment varies from one person to another, because of their unique genetic makeup, their nutritional status, and the characteristics of their particular version of CFS. As you can see from the above, this protocol was initially selected as a means of testing my hypothesis for CFS. In my opinion, it has successfully done that, though I can tell you that there are others with their own hypotheses who don't agree with me on that!
One can go only so far with biochemical theory. To optimize a treatment would require considerable additional testing of alternative protocols, which has not been done, and, I might add, which would be difficult to find funding to do, because the treatment does not involved patented drugs.
What can be said for this protocol is that it is based on Dr. Yasko's treatment experience, and it does have a clinical study behind it that includes objective lab test data.
As you know, there are other treatments advocated by others that are somewhat different from this one, though they all impact the partial methylation cycle block. You mentioned freddd's protocol. There are also the full Yasko treatment program based on genetic testing, the DAN! protocol for autism which is not a fixed protocol, and the Vinitsky protocol (which uses folic acid instead of the reduced forms of folate). Each of these has its adherents, and some have been used by large numbers of people. As far as I know, none of them have been subjected to what I would call objective testing, nor have they been compared with each other in controlled testing. The clinical study we ran on the STA did not have a placebo control group and was not blinded. So, unfortunately, we are left with trying to make decisions based on biochemical theory and a lot of anecdotal information on clinical results. I have expressed my views, based on whatever theory or observations I have, as to what I think are the pros and cons of these protocols, elsewhere in this forum and in other CFS internet groups, but my views have not been objectively tested. So that's where things stand, at least from my point of view.
Best regards,
Rich